Propanc Biopharma, Inc. — Director's Dealing 2021

Aug 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Propanc Biopharma, Inc. (PPCB)
CIK: 0001517681
Period of Report: 2021-08-17

Reporting Person: Kenyon Julian Norman (Director, Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-17	Common stock, par value $0.001	A	3420000	—	Acquired	3420005	Direct